Estrogens and psycho-neurologic status in women

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In the review there are discussed the problems of mental disorders in women connected with hypophysis-ovarian system dysfunction caused by fluctuations in natural menstrual cycle, surgical interventions and ageing (senescence). There are examined the mechanisms of estrogen action on brain function and behavior as well as the possibility of pharmacocorrection.

About the authors

N. S. Sapronov

Institute for Experimental Medicine of the RAMS

Author for correspondence.
Email: medaj@eco-vector.com

Член-корреспондент РАМН

Russian Federation, St. Petersburg

Yu. О. Fedotova

Institute for Experimental Medicine of the RAMS

Email: medaj@eco-vector.com
Russian Federation, St. Petersburg

References

  1. Арушанян З. Б. Лекарственное улучшение познавательной деятельности мозга. Ставрополь: Изд-во СтГМА, 2004.
  2. Бабичев В. H. Нейроэндокринный эффект половых гормонов // Усп. физиол. наук. 2005. Т. 36. № 1. C. 54-67.
  3. Сметник В. П. Индивидуализация подбора заместительной гормонотерапии // Материалы Международной научно-практической конференции «Рациональная заместительная гормонотерапия и качество жизни женщины». 2003. C. 10-12.
  4. Amsterdam J., Garcia-Espana F., Fawsett J. et al. Fluoxetine efficacy in menopausal women with and without estrogen replacement // J. Affect. Disord. 1999. Vol. 55. P. 11-17.
  5. Ashby Jr. C. R., Carr L. A., Cook C. L. et al. Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome // J. Neural. Transm. [Gen Sect]. 1990. Vol. 79. P. 41-51.
  6. Asthana S., Craft S., Baker L. D. et al. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer 's disease: results of a placebo-controlled, double-blind, pilot study // Psychoneuroendocrinol. 1999. Vol. 24 (6). P. 657-677.
  7. Avis N. E., McKinlay S. M The Massachusetts Women's Health Study: an epidemiologic investigation of the menopause // JAMA. 1995. Vol. 50. P. 45-49.
  8. Baldereschi M., DiCarlo A., Lepore V. Estrogen replacement therapy and Alzheimer's disease in the Italian longitudinal study on aging // Neurology. 1998. Vol. 50. P. 996-1002.
  9. Bancroft J., Cook A., Davidson D. et al. Blunting of neuroendocrine responses to infusion of L­tryptophan in women with perimenstrual mood change // Psychol. Med. 1991. Vol. 21. P. 305-312.
  10. Barer B. M. Men and women age differently // Int. J. Age Hum. Dev. 1994. Vol. 38. P. 29-4 0.
  11. Barrett-Connor E., Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women // J. Am. Med. Assoc. 1993. Vol. 269 (20). P. 2637-2641.
  12. Bazzett T. J., Becker J. B. Sex differences in the rapid and acute effects of estrogen in striatal D2 dopamine receptor binding // Brain Res. 1994. Vol. 637. P. 163-172.
  13. Becker J. G., Cha J. Estrous cycle-dependent variation in amphetamine -induced behaviors and striatal dopamine re lea se assessed with microdialysis // Behav. Brain Res. 1989. Vol. 35. P. 117-125.
  14. Berckman L. F., Seeman T. E., Albert M. et al. High usual and imp aired functioning in community dwelling older men and women: findings from the MacArthur Food Research Network on successful aging // J. Clin. Epidemiol. 1993. Vol. 46. P. 1129-1140.
  15. Berman K. F., Schmidt P. J., Rubinow D. R. et al. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women // Proc. Natl. Acad. Sci. USA. 1997. Vol. 94. P. 8836-8841.
  16. Biegon A., McEwen B. S. Modulation by estradiol of serotonin receptors in brain // J. Neurosci. 1982. Vol. 2. P. 199-205.
  17. Biegon A., Reches A., Snyder L., McEwen B. S. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones // Life Sci. 198 3. Vol. 32. P. 20 15-2021.
  18. Birge S. J. The role of estrogen in the treatment of Alzheimer's disease // Neurology. 1997. Vol. 48 (Suppl. 7). P. 36-41.
  19. Biver F., Lotstra F., Monclus M. et al. Sex difference in 5HT2 receptor in the living human brain // Neurosci. Lett. 1996. Vol. 204. P. 25-28.
  20. Blanchet P. J., Fang F., Hyland K. et al. Short­term effects of high-dose 17 beta-estradiol in post-menopausal PD patients: a cross over study // Neurology. 2000. Vol. 53. P. 91-95
  21. Bloch M., Schmidt P., Danaceau M. et al. Effects of gonadal steroids in women with a history of postpartum depression // Am. J. Psychiatry. 2000. Vol. 157. P. 924-930.
  22. Brinton R. D., Proffitt P, Tran J., Luu R. Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mech anism // Exp. Neurol. 1997. Vol. 147. P. 211-220.
  23. Burger H. G., Dudley E. C., Hopper J. L. et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample // J. Clin. Endocrinol. Metab. 1995. Vol. 80. P. 3537-3545.
  24. Castner S. A., Xiao L., Becker J. B. Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies // Brain Res. 1993. Vol. 610. P. 127-134.
  25. Costa M. M., Reus V. I., Wolkowitz O. M. et al. Estrogen replacement therapy and cognitive decline in memory-impaired postmenopausal women // Biol. Psychiatry. 1999. Vol. 46. P. 182-188.
  26. Dean C., Williams R. J., Brockington I. F. Is puer­peral psychosis the same as bipolar manic­depressive disorder? A family study // Psychol. Med. 1989. Vol. 19. P. 637-647.
  27. Decker M. W. The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system // Brain Res. Rev. 1987. Vol. 12. P. 423-4 35.
  28. Drake E. B., Henderson V. W., Stanczyk F. Z. et al. Associations between circulating sex steroid hormones and cognition in normal elderly women // Neurology. 2000. Vol. 54. P. 599-603.
  29. Dubrovsky B.O. Steroids, neuroactive steroids and neurosteroids in psychopathology // Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2005. Vol. 29. P. 169-192.
  30. Duka T., Tasker R., McGowan J. F. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females // Psychopharmacology. 2000. Vol. 149. P. 12 9-139.
  31. Eriksson E., Humb le M. Serotonin in psychiatric pathophysiology: a review of data from experimental and clinical research // The Biologic al Basis of Psychiatric Treatment I R. Pohl, S. Gershon, eds. Basel, Karger, 1990. P. 66-119.
  32. Gibbs R. B., Hashash A., Johnson D. A. Effects of estrogen on potassium-stimulated acetylcholine release in the hippocampus and overlying cortex of adult rats // Brain Res. 1997. Vol. 749. P. 14 3-146.
  33. Gietzen D. W, Hope W G., Woolley D. E. Dopaminergic agonists increase [3H] estradiol binding in hypothalamus of female rats but not males // Life Sci. 1983. Vol. 33. P. 2221-2228.
  34. Gow S. M, Turner E. L., Glasier A. The clinical biochemistry of the menopause and hormone replacement therapy // Ann. Clin. Biochem. 1994. Vol. 31. P. 509-528.
  35. Gregoire A. J. P, Kumar R., Everitt B. et al. Transdermal oestrogen for treatment of severe postnatal depression // Lancet. 1996. Vol. 347. P. 930-933.
  36. Halbreich U. Role of estrogen in postmenopausal depression // Neurology. 1997. Vol. 8 (Suppl. 7). P. 16-20.
  37. Halbreich U., Petty F., Yonkers K. et al. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dycphoric disorder // Am. J. Psychiatry. 1996. Vol. 153. P. 718-719.
  38. Halbreich U., Rojansky N., Palter S. et al. Estrogen augments serotonergic activity in post­menopausal women // Biol. Psychiatry. 1995. Vol. 37. P. 434-441.
  39. Hannah P., Adams D., Glover V, Sandler M Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria // J. Psychiatr. Res. 1992. Vol. 26. P. 69-75.
  40. Henderson V. W. The epidemiology of estrogen replacement therapy and Alzheimer's disease // Neuro logy. 1997. Vol. 48 (Suppl. 7). P. 27-35.
  41. Hogervorst E., Williams J., Budge M. et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive· function in post-menopausal women: a meta-analysis // Neuroscience. 2000. Vol. 101. P. 485-512.
  42. Honjo H., Tanaka K., Kashiwagi T. et al. Senile dementia-Alzheimer's type and estrogen // Horm. Metab. Res. 1995. Vol. 27 (4). P. 204-207.
  43. Hruska R. E., Silbergeld E. K. Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model // Science. 1980. Vol. 208. P. 1466-1467.
  44. Hunter M. S. Emotional well-being, sexual behaviour and hormone replacement therapy // Maturitas. 1992. Vol. 12. P. 299-314.
  45. Jacobs D. M, Tang M X, Stern Y. et al. Cognitive function in nondemented older women who took estrogen after menopause // Neurology. 1998. Vol. 50. P. 368-373.
  46. Janowsky J. S., Chaves B., Orwoll E. Sex steroids modify working memory // J. Cognit. Neurosci. 2000. Vol. 12. P. 407-414.
  47. Kampen D. L., Sherwin B. B. Estrogen use and verbal memory in healthy postmenopausal women // Obstet. Gynecol. 1994. Vol. 83. P. 979-983.
  48. Kaufert P. A., Gilbert P., Tate R. The Manitoba Project: a reexamination of the link between menopause and depression // Maturitas . 1992. Vol. 14. P. 143-155.
  49. Kawas C., Resnick S., Morrison A. et al. A prosoective study of estrogen replacement therapy and the risk of Alzheimer's disease: the Baltimor longitudinal study of aging // Neurology. 1997. Vol. 48. P. 1517-1521.
  50. Kessler R. C., McGonagle K. A., Zhao S. et al. Lifetime and 12-month prevalence of DSM-//I-R psychiatric disorders in the United States // Arch Gen. Psychiatry. 1994. Vol. 51. P. 8-19.
  51. Kimura D. Estrogen replacement therapy may protect against intellectual decline in post­menopausal women // Honn. Behav. 1995. Vol. 29 (3). P. 312-321.
  52. Kogan N., Mills M. Gender influences on age cognitions and preferences: sociocultural or sociobiological? // Psychol. Aging. 1992. Vol. 7. P. 98-106.
  53. Kuhl D. E., Koeppe R. A., Minoshima S. et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer 's disease // Neurology. 1999. Vol. 52. P. 691-699.
  54. LeBlan c E. S., Janowsky J, Chan B. K. S., Nelson H. D. Hormone replacement therapy and cognition: systematic review and meta-analysis // JA MA. 2001. Vol. 285. P. 1489-1499.
  55. Linnoila M., Virkkunen M., George T., Higley D. Impulse control disorders // Int. Clin. Psychopharmacol. 1993. Vol. 8. P. 53-56.
  56. Maki P. M., Resnick S. M. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition // Neurobiol. Aging. 2000. Vol. 21. P. 373-383.
  57. Malikian J E., Hurt S., Endicott .J et al. Premenstrual dysphoric changec in depressed patients // New Research and Program and Abstracts of the American Psychiatric Association 142nd Annual Meeting. Washington DC. Am. Psychiatr. Ass. 1989. P. 128.
  58. Matthews K. A. Myths and realities of the menopause // Psychosom. Med. 1992. Vol. 54. P. 1-9.
  59. McEwen B. S. Estrogen actions throughout the brain // Rec. Prog. Honn. Res. 2002. Vol. 57 (1). P. 357-362.
  60. McEwen B. S., Alves S. E. Estrogen actions in the central nervous system // Endocr. Rev. 1999. Vol. 20. P. 279-307.
  61. McEwen B. S., Alves S. E., Bulloch K., Weiland N. G. Ovarian steroids and the brain: implications for cognition and aging // Neurology. 1997. Vol. 48. P. 8-15.
  62. McMillan P J, Singer C. A., Dorsa D. M The effects of ovariectomy and estrogen replacement on trkA and choline acetyltrans ferase rnRNA expression in the basal forebrain of the adult female Sprague-Daw ley rat // J. Neurosci. 19 96. Vol. 16. P. 1860-1 865.
  63. McQueen J K., Wilson H., Fink G. Estrogen increases serotonin transpo rter (sert) binding sites and sert mRNA expression in female rat brain // Soc. Neurosci. Abstr. 1996. Vol. 22 (Part 1). P. 612.
  64. Menkes D. B., Coates D. C., Fawcett J.P. Acute tryptophan depletion aggravates premenstrual syndrome // J. Affect. Disord. 1994. Vol. 32. P. 37-44.
  65. Mortel K. F, Meyer J. S. Lack of menopausal estrogen replacement therapy and the risk of dementia // J. Neuropsychiatry Clin. Neurosci. 1995. Vol. 7 (3). P. 334-337.
  66. Mulnard R. A., Cotman C. W., Kawas C. et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative study (comment) // JAMA. 2000. Vol. 283. P. 1007-1015.
  67. Namba H., Sokoloff L. Acute administration of high doses of estro gen increases glucose utilization throughout brain // Brain Res. 1984. Vol. 291. P. 391-394.
  68. Nehlig A., Parrino L. J., Crane A. M, Sokoloff L. Local cerebral glucose utilization in normal female rats: variations during estrous cycle and comparison with males // J. Cereb. Blood Elow Metab. 1985. Vol. 5. P. 393-4 00.
  69. 'Hara M W., Schlecte J. A., Lewis D. A., Varner M. W. Controlled prospective study of post­partum mood disorders: psychological, environmental and hormonal variables // J. Abnorm. Psychol. 1991. Vol. 100. P. 6 3-73.
  70. Ohkura T., Isse K., Akazawa K. et al. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer 's type: 7 case reports // Dementia. 1995. Vol. 6 (2). P. 99-107.
  71. Parry B. L. Reproductive factors affecting the course of affective illness in women // Psychiatr. Clin. North. Am. 1989. Vol. 12. P. 207-220.
  72. Paul S. M, Purdy R. H. Neuroactive steroids // FASEB J. 1992. Vol. 6. P. 2311-2322.
  73. Pecins-Thompson M., Brown N. A., Kohama S. G., Bethea C. L. Ovarian steroid regulation of tryptophane hydroxylase mRNA expression in rhesus macaques // J. Neurosci. 1996. Vol. 16. P. 7021-70 29.
  74. Pigott T A. Anxiety disorders in women // Psychiatry Clin. North Am. 2003. Vol. 26. P. 621-672.
  75. Polo-Kantola P., Portin R., Polo J. et al. The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, crossover trial in postmenopausal women // Obstet. Gyn. 1998. Vol. 91. P. 459-466.
  76. Power R. F, Mani S. K., Codin J. et al. Dopaminergic and ligand -independent activation of steroid hormone receptors // Sc ie nce. 1991. Vol. 254. P. 1636-1639.
  77. Rapkin A. J., Morgan M., Goldman L. et al. Progesterone metabolite allopregnanolone in women with premenstrual syndrome // Obstet. Ginecol. 1997. Vol. 90. P. 709-714.
  78. Reame N. E. Gona dotropin changes in the perimenopause // Proc. Int. Symp. Perimenopause I Lobo R. A., ed. NY: Springer-Verlag, 1997. P. 157-169.
  79. Resnick S. M., Maki P.M., Golski S. et al. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance // Horm. Behav. 1998. Vol. 34. P. 171-182.
  80. Resnick S. M, Metter E. J., Zonderman A. B. Estrogen replacement therapy and longitudinal dekline in visual memory: A possible protective effect? // Neurology. 1997. Vol. 49. P. 1491-1497.
  81. Rivera-Tovar A. D., Frank E. Late luteal phase dycphoric disorder in young women // Am. J. Psychiatry. 1990. Vol. 147. P. 1634-1636.
  82. Rubinow D. R., Schmidt P. J. Menstrual cycle­related and perimenopause-related affective disorders // Psychoneuro endocrinol. The Scientific Basis of Clinical Practice I Wolkowitz 0., Rothschild A., eds. Am. Psychiatric Publ. Inc. Washington-London, 2003. P. 245-280.
  83. Saceda M., Knabbe G., Dickson R. B. et al. Post­transcriptional destabilization of estrogen receptor mDNA in MCF-7 cells by 12-O-tetrade­canoylphorbol-l 3-acetate // J. Biol. Chem. 1991. Vol. 266. P. 17809-178 14.
  84. Sackeim H. A., Devanand D. P., Nobler M S. Electroconvulsive therapy // Psychopharmacology: the Fourth Generation of Progress I M. Bloom, D. J. Kupfer, eds. NY: Raven Press, 1995. P. 112 6-114 1.
  85. Sanacora G., Mason G. S., Rothman D. L. et al. Decrease d cortical GABA levels in major depression as determined by 1H-MRS // Society for Neuroscience. Vol 484.12. Los-Angeles, 1998. P. 1238.
  86. Santoro N., Brown J. R., Adel T. et al. Characterization of reproductive hormonal dynamics in the perimenopause // J. Clin. Endocrinol. Metab. 1996. Vol. 81. P. 1495-1501.
  87. Schmidt R., Fazekas F., Reinhart B. et al. Estrogen replacement therapy in older women: a neuropsychological and brain MRI study // J. Am. Geriatr. Soc. 1996. Vol. 44. P. 1307-1313.
  88. Schmidt P. J., Roca C. A., Bloch M, Rubinow D. R. The perimenopause and affective disorders // Semin. Rep rod. Endocrinol. 1997. Vol. 15. P. 91 -100.
  89. Schneider L. S., Farlow M. Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease // Ann. NY Acad. Sci. 1997. Vol. 826. P. 317-322.
  90. Schneider L., Small G. W., Hamilton S. H. et al. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial // Am. J. Geriatr. Psychiatry. 199 7. Vol. 5 (2). P. 97-106.
  91. Seifer D. B., Naftolin F. Moving toward an earlier and better understanding of perimenopause // Fertil. Steril. 1998. Vol. 69. P. 387-388.
  92. Seshadri S., Zornberg G. L., Derby l. E. et al. Drachman Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease // Arch. Neural. 2001. Vol. 58. P. 435-440.
  93. Shaywitz S. E., Shaywitz B. A., Pugh K. R. et al. Effects of estrogen on brain activation patterns in postmenopausal women during working memory tasks // JAMA. 1999. Vol. 281. P. 1197-1202.
  94. Sherwin B. B. Estrogen effects on cognition in menopausal women // Neurology. 1997. Vol. 48 (Suppl. 7). P. 21-26.
  95. Sherwin B. B. Estrogen and cognitive function troughout the female life spain // Neuronal and Cognitive Effects of Estrogens I Chadwick D. J. et al., eds. Novartis Found Symp. 230. Chichester, Wiley. 2000. P. 188-201.
  96. Sherwin B. B., Tulandi T. «Add-back» estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata utery [see comments] // J. Clin. Endocrinol. Metab. 1996. Vol. 81. P. 2545-2549.
  97. Shumaker S. A., Legault C., Wallance R. B. et al. Estrogen plus progestin and the incidence of dementia and mild cog,1itive impairment in post­menopausal women: the Women's health Initiative Memory Study: a randomized controlled trial // JAMA. 2003. Vol. 289. P. 2651-2662.
  98. Sichel D. A., Cohen L. S., Robertson L. M et al. Prophylactic estrogen in recurrent poatpartum affective disorder // Biol. Psychiatry. 1995. Vol. 38. P. 814-818.
  99. Singh M., Meyer E. M, Simpkins J. W. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocamp al brain regions in female Sprague­ Dawley rats // Endocrinology. 1995. Vol. 136. P. 2320-2324.
  100. Stanford J. L. The benefits of hormone replacement therapy outweigh the breast-cancer risks for some women // J. NIH Res. 1996. Vol. 8. P. 40-44.
  101. Stumpf W. E., Grant L. D. Anatomical Neuroendocrinology. NY: Karger, 1975.
  102. Su T.-P., Schmidt P J., Danaceau M. et al. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls // J. Clin. Endocrinol. Metab. 1997. Vol. 82. P. 1220-1228.
  103. Sumner B. E. H., Fink G. Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain // Mol. Cell. Neurosci. 1993. Vol. 4. P. 83-92.
  104. Sumner B. E. H., Fink G. The density of 5-hydroxytryptamine2A receptors in forebrain is increased in pro-oestrus in intact female rats // Neurosci. Lett. 1997 . Vol. 234. P. 7-10.
  105. Thompson T. L., Moss R. L. Modulation of mesolimbic dopaminergic activity over the rat estrous cycle // Neurosci. Lett. 1997. Vol. 229. P. 145-148.
  106. Toran-Allerand C. D. The estrogen/neurotrophin connection during neural development: is colocalization of estrogen receptors with the neurotrophins and their receptors biologically relevant? // Dev. Neurosci. 1996. Vol. 18. P. 36-4 8.
  107. Touxefis D. J., Myers K. M., Davis M. The effect of gonadal hormones and gender on anxiety and emotional learning // Horm. Behav. 2006. Vol. 50. P. 539-549.
  108. Veeninga A. T., Westenberg H. G. M. Serotonergic function and late luteal phase dysphoric disorder // Psychopharmacology. 1992. Vol. 108. P. 153-158.
  109. Warner P., Ban croft J., Dixson A. et al. The relationschip between perimenstrual depressive mood and depressive illness // J. Affect. Disord. 1991. Vol. 23. P. 9-23.
  110. Weiner R. I., Ganong W. F. Role of brain monoamine and hist amine in regulation of anterior pituitary secretions // Physiol. Rev. 1978. Vol. 58. P. 905-976.
  111. Wickelgren I. Estrogen stakes claim to cognition // Science. 1997. Vol. 276. P. 6 75-678.
  112. Wise P M., Dubai D. B., Wilson M E. et al. Estrogens: trophic and protective factors in the adult brain // Fron t. Neuroendocrinol. 2001. Vol. 22. P. 33-66.
  113. Wolf O., Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men // Horm. Behav. 2002. Vol. 41. P. 259-266.
  114. Wolf O. T., Kudielka B. M, Hellhammer D. H. et al. Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels // Psychoneuroendocrinology. 1999. Vol. 24. P. 727-741.
  115. Woolley D. E., Hope W. G., Thompson M A. et al. Dopaminergic stimulation of estrogen receptor binding in vivo: a reexamination // Recent Prog. Horm. Res. 1994. Vol. 49. P. 383-393.
  116. Yaffe K., Lui L.-Y, Grady D. et al. Cognitive decline in women in relation to non-proteinbound oestradiol concentrations // Lancet. 2000. Vol. 356. P. 708-712.
  117. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia // JAMA. 19 98. Vol. 279. P. 688-695.
  118. Yonkers K. A. The association between premenstrual dysphoric disorder and other mood disorders // J. Clin. Psychiatry. 1997. Vol. 58 (Suppl.). P. 19-25.
  119. Zweifel J. E., O 'Brien W. H. A meta-analysis of the effect of hormone replacement therapy on depressed mood // Psycho neuroendocrinology. 1997. Vol. 22. P. 189-212

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2007 Sapronov N.S., Fedotova Y.О.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.